Mr. Cline is an accomplished biopharmaceutical executive with over 25 years of commercial experience and was previously Executive Vice President, Commercial and a member of the Executive Committee at Seattle Genetics, where he oversaw all marketing, sales, and managed markets functions.
Read More
Ms. Jacques currently serves as Chief Executive Officer of Enzyvant Therapeutics, Inc, a private biopharmaceutical company focused on developing therapies for patients with rare diseases.
Read More
The SAC will collaborate with the MediPharm Labs management team on advancements in the emerging fields of cannabinoid extraction and cannabinoid-based derivative science.
Read More
Currently, Gatto-Bellora is the founder and President of Hair Ventures, LLC and founder and CEO of Daumdeuman, LLC.
Read More
The appointment of a Lead Independent Director supports Aleafia Health’s goal of good corporate governance practices in accordance with the guidelines set out in National Policy 58-201 Corporate Governance Guidelines.
Read More
Get stock alerts, news & related alerts straight to your inbox!